Literature DB >> 20170881

Intravenous ascorbic acid infusion improves myocardial perfusion grade during elective percutaneous coronary intervention: relationship with oxidative stress markers.

Stefania Basili1, Gaetano Tanzilli, Enrico Mangieri, Valeria Raparelli, Serena Di Santo, Pasquale Pignatelli, Francesco Violi.   

Abstract

OBJECTIVES: Our goal was to explore whether antioxidant vitamin C infusion is able to affect the microcirculation perfusion in patients undergoing elective percutaneous coronary intervention for stable angina.
BACKGROUND: Periprocedural myocardial injury in the setting of elective percutaneous coronary intervention is associated with increased risk of death, recurrent infarction, and revascularization at follow-up. Despite excellent epicardial blood flow, impaired microcirculatory reperfusion may persist and increases the risk of vascular recurrences. Post-percutaneous coronary intervention induced-oxidative stress is one of the potential mechanisms accounting for impaired perfusion.
METHODS: Fifty-six patients were enrolled in a prospective, single-center, randomized study comparing 1 g vitamin C infusion (16.6 mg/min, over 1 h before percutaneous coronary intervention) versus placebo.
RESULTS: At the baseline, Thrombolysis In Myocardial Infarction (TIMI) myocardial perfusion grade <2 was observed in 89% and in 86% of patients randomized to the placebo or vitamin C infusion group, respectively (p > 0.05). After percutaneous coronary intervention, these percentages decreased in the placebo group (32%) and in greater measure in the vitamin C group (4%, p < 0.01). Complete microcirculatory reperfusion (TIMI myocardial perfusion grade = 3) was achieved in 79% of the vitamin C-treated group compared with 39% of the placebo group (p < 0.01); 8-hydroxy-2-deoxyguanosine (p < 0.002) and 8-iso-prostaglandin F(2alpha) (p < 0.02) plasma levels significantly increased in the placebo group while they were significantly reduced in the vitamin C-treated group (p < 0.0001). TIMI myocardial perfusion grade changes from the baseline showed significant correlation with 8-hydroxy-2-deoxyguanosine (p < 0.006) or 8-iso-prostaglandin F(2alpha) (p < 0.01) plasma levels changes.
CONCLUSIONS: In patients undergoing elective percutaneous coronary intervention, impaired microcirculatory reperfusion is improved by vitamin C infusion suggesting that oxidative stress is implicated in such a phenomenon. Copyright (c) 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20170881     DOI: 10.1016/j.jcin.2009.10.025

Source DB:  PubMed          Journal:  JACC Cardiovasc Interv        ISSN: 1936-8798            Impact factor:   11.195


  22 in total

1.  Vitamin C and percutaneous coronary intervention.

Authors:  Patrice Delafontaine; Asif Anwar
Journal:  JACC Cardiovasc Interv       Date:  2010-02       Impact factor: 11.195

Review 2.  Vitamin C and thiamine in critical illness.

Authors:  A M E Spoelstra-de Man; H M Oudemans-van Straaten; P W G Elbers
Journal:  BJA Educ       Date:  2019-07-05

3.  Patients with microvascular obstruction after primary percutaneous coronary intervention show a gp91phox (NOX2) mediated persistent oxidative stress after reperfusion.

Authors:  Giampaolo Niccoli; Andrea Celestini; Camilla Calvieri; Nicola Cosentino; Elena Falcioni; Roberto Carnevale; Cristina Nocella; Francesco Fracassi; Marco Roberto; Roberta P Antonazzo; Pasquale Pignatelli; Filippo Crea; Francesco Violi
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2013-09-05

4.  Amelioration of persistent left ventricular function impairment through increased plasma ascorbate levels following myocardial infarction.

Authors:  Nicolás Valls; Juan G Gormaz; Rubén Aguayo; Jaime González; Roberto Brito; Daniel Hasson; Matías Libuy; Cristóbal Ramos; Rodrigo Carrasco; Juan C Prieto; Gastón Dussaillant; Ángel Puentes; Viviana Noriega; Ramón Rodrigo
Journal:  Redox Rep       Date:  2016-02-24       Impact factor: 4.412

5.  Association of Smoking and Other Factors With the Outcome of Mohs Reconstruction Using Flaps or Grafts.

Authors:  Chang Ye Wang; Jacob Dudzinski; Derek Nguyen; Eric Armbrecht; Ian A Maher
Journal:  JAMA Facial Plast Surg       Date:  2019-09-01       Impact factor: 4.611

6.  Prevention of postoperative atrial fibrillation: novel and safe strategy based on the modulation of the antioxidant system.

Authors:  Ramón Rodrigo
Journal:  Front Physiol       Date:  2012-04-12       Impact factor: 4.566

Review 7.  Vitamin C revisited.

Authors:  Heleen M Oudemans-van Straaten; Angelique Me Spoelstra-de Man; Monique C de Waard
Journal:  Crit Care       Date:  2014-08-06       Impact factor: 9.097

8.  Prognostically relevant periprocedural myocardial injury and infarction associated with percutaneous coronary interventions: a Consensus Document of the ESC Working Group on Cellular Biology of the Heart and European Association of Percutaneous Cardiovascular Interventions (EAPCI).

Authors:  Heerajnarain Bulluck; Valeria Paradies; Emanuele Barbato; Andreas Baumbach; Hans Erik Bøtker; Davide Capodanno; Raffaele De Caterina; Claudio Cavallini; Sean M Davidson; Dmitriy N Feldman; Péter Ferdinandy; Sebastiano Gili; Mariann Gyöngyösi; Vijay Kunadian; Sze-Yuan Ooi; Rosalinda Madonna; Michael Marber; Roxana Mehran; Gjin Ndrepepa; Cinzia Perrino; Stefanie Schüpke; Johanne Silvain; Joost P G Sluijter; Giuseppe Tarantini; Gabor G Toth; Linda W Van Laake; Clemens von Birgelen; Michel Zeitouni; Allan S Jaffe; Kristian Thygesen; Derek J Hausenloy
Journal:  Eur Heart J       Date:  2021-07-15       Impact factor: 29.983

Review 9.  Molecular basis of cardioprotective effect of antioxidant vitamins in myocardial infarction.

Authors:  Ramón Rodrigo; Matías Libuy; Felipe Feliú; Daniel Hasson
Journal:  Biomed Res Int       Date:  2013-07-14       Impact factor: 3.411

10.  The effectiveness of antioxidant vitamins C and E in reducing myocardial infarct size in patients subjected to percutaneous coronary angioplasty (PREVEC Trial): study protocol for a pilot randomized double-blind controlled trial.

Authors:  Ramón Rodrigo; Daniel Hasson; Juan C Prieto; Gastón Dussaillant; Cristóbal Ramos; Lucio León; Javier Gárate; Nicolás Valls; Juan G Gormaz
Journal:  Trials       Date:  2014-05-29       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.